Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment

References

• UK CR. Hodgkin lymphoma survival 2013–2017 [cited 2021 Mar 21]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/hodgkin-lymphoma/survival#ref-; http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/hodgkin-lymphoma#heading-Two
   Google Scholar
• Ansell SM. Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond. Am J Hematol. 2016;91(1):109–112.
   PubMed Web of Science ®Google Scholar
• Devita VT Jr., Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970;73(6):881–895.
   PubMed Web of Science ®Google Scholar
• Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–2715.
   PubMed Web of Science ®Google Scholar
• Matasar MJ, Ford JS, Riedel ER, et al. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood. J Natl Cancer Inst. 2015;107(4):djv018.
   PubMedGoogle Scholar
• Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582.
   PubMed Web of Science ®Google Scholar
• Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304(2):172–179.
   PubMed Web of Science ®Google Scholar
• Constine LS, Donaldson SS, McDougall RI, et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer. 1984;53(4):878–883.
   PubMed Web of Science ®Google Scholar
• Glatstein E, McHardy-Young S, Brast N, et al. Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab. 1971;32(6):833–841.
   PubMed Web of Science ®Google Scholar
• Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med. 1991;325(9):599–605.
   PubMed Web of Science ®Google Scholar
• Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Boil Phys. 1995;31(5):1165–1170.
   PubMed Web of Science ®Google Scholar
• Inskip PD, Veiga LHS, Brenner AV, et al. Hypothyroidism after radiation therapy for childhood cancer: a report from the childhood cancer survivor study. Radiat Res. 2018;190(2):117–132.
   PubMed Web of Science ®Google Scholar
• Lollert A, Gies C, Laudemann K, et al. Ultrasound evaluation of thyroid gland pathologies after radiation therapy and chemotherapy to treat malignancy during childhood. Int J Radiat Oncol Biol Phys. 2016;94(1):139–146.
   PubMed Web of Science ®Google Scholar
• Shalet SM, Rosenstock JD, Beardwell CG, et al. Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood. Clin Radiol. 1977;28(5):511–515.
   PubMed Web of Science ®Google Scholar
• Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the childhood cancer survivor study. J Clin Endocrinol Metab. 2000;85(9):3227–3232.
   PubMed Web of Science ®Google Scholar
• Healy JC, Shafford EA, Reznek RH, et al. Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's disease. Br J Radiol. 1996;69(823):617–623.
   PubMed Web of Science ®Google Scholar
• Veiga LH, Bhatti P, Ronckers CM, et al. Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2012;21(1):92–101.
   PubMed Web of Science ®Google Scholar
• Johnson PW, Radford JA, Cullen MH, et al. Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom lymphoma group LY09 trial (ISRCTN97144519). J Clin Oncol. 2005;23(36):9208–9218.
   PubMed Web of Science ®Google Scholar
• SEER*Rx interactive antineoplastic drugs database; 2020.
   Google Scholar
• CACI. ACORN. Available from: https://www.caci.co.uk/sites/default/files/resources/Acorn_User_Guide_0.pdf. 2011
   Google Scholar
• Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–706.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–481.
   Web of Science ®Google Scholar
• StataCorp. Stata statistical software: release 16. College Station (TX): StataCorp LP; 2019.
   Google Scholar
• Stewart RR, David CL, Eftekhari F, et al. Thyroid gland: US in patients with Hodgkin disease treated with radiation therapy in childhood. Radiology. 1989;172(1):159–163.
   PubMed Web of Science ®Google Scholar
• Cella L, Conson M, Caterino M, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1802–1808.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Ramsay NKC, Bantle JP, et al. Thyroid abnormalities after therapy for Hodgkin's disease in childhood. Oncologist. 1996;1:62–67.
   PubMedGoogle Scholar
• Gebauer J, Fick EM, Waldmann A, et al. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany. Eur J Endocrinol. 2015;173(2):139–148.
   PubMed Web of Science ®Google Scholar
• Mostoufi-Moab S, Seidel K, Leisenring WM, et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2016;34(27):3240–3247.
   PubMed Web of Science ®Google Scholar
• Hawkins MM, Robison LL. Importance of clinical and epidemiological research in defining the long-term clinical care of pediatric cancer survivors. Pediatr Blood Cancer. 2006;46(2):174–178.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Usa T, Tominaga T, et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55–58 years after radiation exposure. JAMA. 2006;295(9):1011–1022.
   PubMed Web of Science ®Google Scholar
• Kuten A, Lubochitski R, Fishman G. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol. 1996;61(4):281–283.
   PubMed Web of Science ®Google Scholar
• Nelson DF, Reddy KV, O'Mara RE, et al. Thyroid abnormalities following neck irradiation for Hodgkin's disease. Cancer. 1978;42(6):2553–2562.
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369–384.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995;43(1):55–68.
   PubMed Web of Science ®Google Scholar
• Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer prevalence UK data tables. London: NCRAS; 2015.
   Google Scholar
• Bethge W, Guggenberger D, Bamberg M, et al. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol. 2000;79(3):114–118.
   PubMed Web of Science ®Google Scholar
• Vassilakopoulos TP, Chatzidimitriou C, Asimakopoulos JV, et al. Immunotherapy in Hodgkin lymphoma: present status and future strategies. Cancers. 2019;11(8):1071.
   PubMed Web of Science ®Google Scholar
• Illouz F, Drui D, Caron P, et al. Expert opinion on thyroid complications in immunotherapy. Ann Endocrinol. 2018;79(5):555–561.
   PubMed Web of Science ®Google Scholar
• Koh ES, Tran TH, Heydarian M, et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Radiat Oncol. 2007;2:13.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Lundemann M, Vogelius IR, et al. A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma. Radiother Oncol. 2015;114(2):206–211.
   PubMed Web of Science ®Google Scholar
• Louie AD, Robison LL, Bogue M, et al. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant. 2000;25(11):1191–1196.
   PubMed Web of Science ®Google Scholar
• Sidorkiewicz S, Malmartel A, Prevost L, et al. Patient-physician agreement in reporting and prioritizing existing chronic conditions. Ann Fam Med. 2019;17(5):396–402.
   PubMed Web of Science ®Google Scholar